A detailed history of Burleson & Company, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Burleson & Company, LLC holds 80 shares of MDT stock, worth $6,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 80 -0.0%
Holding current value
$6,482
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022

BUY
$80.75 - $95.31 $1,615 - $1,906
20 Added 33.33%
80 $6,000
Q2 2022

Jul 13, 2022

BUY
$87.4 - $113.09 $874 - $1,130
10 Added 20.0%
60 $5,000
Q1 2022

Apr 25, 2022

BUY
$100.58 - $112.38 $3,017 - $3,371
30 Added 150.0%
50 $6,000
Q4 2021

Jan 25, 2022

BUY
$99.53 - $127.75 $1,990 - $2,555
20 New
20 $2,000
Q2 2021

Jul 22, 2021

SELL
$118.19 - $131.5 $11,819 - $13,150
-100 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$111.18 - $119.74 $11,118 - $11,974
100 New
100 $12,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.